Rating History for Gossamer Bio Inc. (GOSS) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/24/2026 | Eliana Merle | Downgrade | Underweight (Overweight) |
0.30 (9.00) |
2.13 (0.50) |
-76.53% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/24/2026 | Eliana Merle | Downgrade | Underweight (Overweight) |
0.30 (9.00) |
2.13 (0.50) |
-76.53% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||